Poolbeg Pharma PLC – Oral Vaccine Programme Moves Forward

Poolbeg Pharma announces an update to its Oral Vaccine Programme following the award of non-dilutive grant funding by the Irish Government’s Disruptive Technologies Innovation Fund in November 2022, as part of the Poolbeg led EncOVac Consortium.

Scroll to Top